| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Samuel J Livingston, Eva Yi Chou, Teagen D Quilichini, Jonathan E Page, A Lacey Samuel. Overcoming the challenges of preserving Lipid-rich Cannabis sativa L. glandular trichomes for transmission electron microscopy. Journal of microscopy. 2022-12-21. PMID:36542368. |
advances in cryofixation methods has resulted in ultrastructural observations closer to the 'natural state' of the living cell, and recent reports of cryofixed cannabis trichome ultrastructure challenge the long-standing model of cannabinoid trafficking proposed by ultrastructural reports using chemically fixed samples. |
2022-12-21 |
2023-08-14 |
Not clear |
| Calvin Diep, Akash Goel, Duminda N Wijeysundera, Hance Clarke, Karim S Ladh. Co-use of cannabis and prescription opioids in adults in the USA: a population-based, cross-sectional analysis of the NHANES from 2009 to 2018. Regional anesthesia and pain medicine. 2022-12-21. PMID:36543390. |
cannabis and cannabinoids continue to gain popularity as adjuncts or alternatives to opioids in pain management, with evolving evidence of effectiveness. |
2022-12-21 |
2023-08-14 |
Not clear |
| Arjola Agolli, Olsi Agolli, Selia Chowdhury, Vallabh Shet, Johanna S Canenguez Benitez, Niharika Bheemisetty, Madeeha Subhan Walee. Increased cannabis use in pregnant women during COVID-19 pandemic. Discoveries (Craiova, Romania). vol 10. issue 2. 2022-12-19. PMID:36530177. |
the action of cannabis on endocannabinoid receptors might cause poor blastocyst implantation, inhibition of decidualization, compromised placentation, miscarriage and poor embryo development.the children born to mothers who used cannabis during pregnancy manifested higher aggression, anxiety, hyperactivity, and higher levels of the hormone cortisol, compared to children of non-cannabis users. |
2022-12-19 |
2023-08-14 |
Not clear |
| Yang Liu, Sansan Jia, Jiajia Wang, Dan Wang, Xinxin Zhang, Huiqing Liu, Fang Zhou, Zhihao Zhang, Qi Li, Hailong Dong, Haixing Zhon. Endocannabinoid signaling regulates post-operative delirium through glutamatergic mediodorsal thalamus-prelimbic prefrontal cortical projection. Frontiers in aging neuroscience. vol 14. 2022-12-19. PMID:36533179. |
previous studies demonstrated that cannabis use might cause delirium-like behavior through the endocannabinoid system (ecbs), a widely distributed retrograde presynaptic neuromodulator system. |
2022-12-19 |
2023-08-14 |
Not clear |
| Barliz Waissengrin, Yasmin Leshem, Marwa Taya, David Meiri, Ofer Merimsky, Sivan Shamai, Ido Wolf, Tami Rubine. The use of medical cannabis concomitantly with immune checkpoint inhibitors in non-small cell lung cancer: A sigh of relief? European journal of cancer (Oxford, England : 1990). vol 180. 2022-12-19. PMID:36535195. |
as the cannabinoid receptors are abundantly expressed and modulate immune cells, it has been hypothesised that cannabis may attenuate the activity of icis. |
2022-12-19 |
2023-08-14 |
Not clear |
| Yuxi Li, Xilin Li, Patrick Cournoyer, Supratim Choudhuri, Xiaozhong Yu, Lei Guo, Si Che. Cannabidiol-induced transcriptomic changes and cellular senescence in human Sertoli cells. Toxicological sciences : an official journal of the Society of Toxicology. 2022-12-15. PMID:36519830. |
cannabidiol (cbd), one of the major cannabinoids in the plant cannabis sativa l., is the active ingredient in a drug approved for the treatment of seizures associated with certain childhood-onset epileptic disorders. |
2022-12-15 |
2023-08-14 |
mouse |
| Natasha M C Oliveira, Dayane A Machado, Thauann L da Silva, Gabriel T do Val. Treatment with Cannabidiol Results in an Antioxidant and Cardioprotective Effect in Several Pathophysiologies. Current hypertension reviews. vol 18. issue 2. 2022-12-12. PMID:36508270. |
cannabis sativa has chemically active compounds called cannabinoids, where Δ9- tetrahydrocannabinol (thc) and cannabidiol (cbd) are the major ones responsible for the various pharmacological effects. |
2022-12-12 |
2023-08-14 |
Not clear |
| Natalia Galant, Jakub Czarny, Jolanta Powierska-Czarny, Agnieszka Piotrowska-Cypli. Development and Validation of the LC-MS/MS Method for Determination of 130 Natural and Synthetic Cannabinoids in Cannabis Oil. Molecules (Basel, Switzerland). vol 27. issue 23. 2022-12-11. PMID:36500694. |
development and validation of the lc-ms/ms method for determination of 130 natural and synthetic cannabinoids in cannabis oil. |
2022-12-11 |
2023-08-14 |
Not clear |
| Lucy A Chester, Amir Englund, Edward Chesney, Dominic Oliver, Jack Wilson, Simina Sovi, Alex M Dickens, Matej Oresic, Tuomas Linderman, John Hodsoll, Amedeo Minichino, John Strang, Robin M Murray, Tom P Freeman, Philip McGuir. Effects of Cannabidiol and Delta-9-Tetrahydrocannabinol on Plasma Endocannabinoid Levels in Healthy Volunteers: A Randomized Double-Blind Four-Arm Crossover Study. Cannabis and cannabinoid research. 2022-12-09. PMID:36493386. |
effects of cannabidiol and delta-9-tetrahydrocannabinol on plasma endocannabinoid levels in healthy volunteers: a randomized double-blind four-arm crossover study. |
2022-12-09 |
2023-08-14 |
human |
| Hans Törnblo. Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency. Alimentary pharmacology & therapeutics. vol 57. issue 1. 2022-12-08. PMID:36480709. |
editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency. |
2022-12-08 |
2023-08-14 |
Not clear |
| Christopher N Andrews, Keith A Sharke. Editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency-authors' reply. Alimentary pharmacology & therapeutics. vol 57. issue 1. 2022-12-08. PMID:36480721. |
editorial: cannabis use disorders at the emergency department, a sign of a growing cannabinoid emergency-authors' reply. |
2022-12-08 |
2023-08-14 |
Not clear |
| Manikandan Palrasu, Lillianne Wright, Manish Patel, Lindsey Leech, Scotty Branch, Shea Harrelson, Saeed Kha. Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We? Medical cannabis and cannabinoids. vol 5. issue 1. 2022-12-05. PMID:36467783. |
for example, cannabinoids, the most popular and biologically active chemicals in cannabis, aid in many clinical ailments, including pain, inflammation, epilepsy, sleep disturbances or insomnia, multiple sclerosis, anorexia, schizophrenia, neurodegenerative diseases, anti-nausea, and most importantly, cancer. |
2022-12-05 |
2023-08-14 |
Not clear |
| Manikandan Palrasu, Lillianne Wright, Manish Patel, Lindsey Leech, Scotty Branch, Shea Harrelson, Saeed Kha. Perspectives on Challenges in Cannabis Drug Delivery Systems: Where Are We? Medical cannabis and cannabinoids. vol 5. issue 1. 2022-12-05. PMID:36467783. |
the current article presents a perspective on (1) a working knowledge of cannabinoids and their mechanisms of action, (2) the landscape of using medicinal cannabis for cancer-related medical conditions along with adversities, (3) current approaches, formulations, and challenges in medicinal cannabis delivery systems (oral, transdermal, pulmonary, and transmucosal), and lastly, (4) emerging approaches to improve delivery systems. |
2022-12-05 |
2023-08-14 |
Not clear |
| Riley D Kirk, Toyosi Akanji, Huifang Li, Jie Shen, Saleh Allababidi, Navindra P Seeram, Matthew J Bertin, Hang M. Evaluations of Skin Permeability of Cannabidiol and Its Topical Formulations by Skin Membrane-Based Parallel Artificial Membrane Permeability Assay and Franz Cell Diffusion Assay. Medical cannabis and cannabinoids. vol 5. issue 1. 2022-12-05. PMID:36467778. |
cannabinoids including cannabidiol (cbd) have attracted enormous interest as bioactive ingredients for various dermatological and/or cosmeceutical uses. |
2022-12-05 |
2023-08-14 |
Not clear |
| John S Markowitz, Ludmila De Faria, Qingchen Zhang, Philip W Melchert, Reginald F Frye, Brandon O Klee, Yuli Qia. The Influence of Cannabidiol on the Pharmacokinetics of Methylphenidate in Healthy Subjects. Medical cannabis and cannabinoids. vol 5. issue 1. 2022-12-05. PMID:36467779. |
cannabidiol (cbd) is a widely utilized nonpsychoactive cannabinoid available as an over-the-counter supplement, a component of medical cannabis, and a prescriptive treatment of childhood epilepsies. |
2022-12-05 |
2023-08-14 |
human |
| Susanne Schilling, Rainer Melzer, Caroline A Dowling, Jiaqi Shi, Shaun Muldoon, Paul F McCab. A protocol for rapid generation cycling (speed breeding) of hemp (Cannabis sativa) for research and agriculture. The Plant journal : for cell and molecular biology. 2022-12-02. PMID:36458321. |
furthermore, non-hallucinogenic cannabinoids like cannabidiol (cbd), which can be extracted from female hemp flowers, are potentially valuable pharmacological compounds. |
2022-12-02 |
2023-08-14 |
Not clear |
| Akira Namera, Shigenori Ota, Yasuhiro Tomioka, Takeshi Saito, Masataka Naga. Facile determination of natural cannabinoids in cannabis products using a conventional fully porous particle column and isocratic high-performance liquid chromatography with diode-array detector. Forensic toxicology. vol 40. issue 2. 2022-12-01. PMID:36454421. |
facile determination of natural cannabinoids in cannabis products using a conventional fully porous particle column and isocratic high-performance liquid chromatography with diode-array detector. |
2022-12-01 |
2023-08-14 |
Not clear |
| Taís B Rodrigues, Mônica P Souza, Lilian de Melo Barbosa, Júlio de Carvalho Ponce, Luiz F Neves Júnior, Maurício Yonamine, Jose Luiz Cost. Synthetic cannabinoid receptor agonists profile in infused papers seized in Brazilian prisons. Forensic toxicology. vol 40. issue 1. 2022-12-01. PMID:36454481. |
synthetic cannabinoid receptor agonists (scras) are a class of varied compounds that mimic the effects of natural cannabinoids found in cannabis. |
2022-12-01 |
2023-08-14 |
Not clear |
| Sonaal Ramlugon, Ruby-Ann Levendal, Carminita L Fros. Effect of oral cannabis administration on the fat depots of obese and streptozotocin-induced diabetic rats. Phytotherapy research : PTR. 2022-11-28. PMID:36437580. |
cannabis concentration of 1.25 mg/kg body weight (relative to thc content) was effective in reversing insulin-resistance in the rat model, unlike the other higher cannabinoid concentrations. |
2022-11-28 |
2023-08-14 |
rat |
| Greg Klazura, Joseph R Geraghty, Marko Rojnica, Thomas Sims, Nathaniel Koo, Thom Lob. Cannabinoid Hyperemesis Syndrome Complicated by Pneumomediastinum: Implications for Pediatric Surgeons. Clinical surgery journal. vol 5. issue Suppl 13. 2022-11-28. PMID:36438163. |
cannabinoid hyperemesis syndrome (chs) is a form of cyclic vomiting syndrome characterized by episodic vomiting occurring every few weeks or months and is associated with prolonged and frequent use of high-dose cannabis. |
2022-11-28 |
2023-08-14 |
Not clear |